Shl Telemedicine AI Stock Analysis
Want to see CH:SHLTN full AI Analyst Report?
Shl Telemedicine (SHLTN) AI Stock Analysis
Shl Telemedicine
(Six Swiss:SHLTN)
The overall score is 42, reflecting significant financial distress. The primary concern is the company's persistent cash burn and unprofitability, which heavily weigh on the Financial Performance and Valuation scores. While the balance sheet is not overleveraged and technicals are neutral, these factors are insufficient to offset the fundamental risks of ongoing losses and negative cash flows.
Shl Telemedicine (SHLTN) vs. iShares MSCI Switzerland ETF (EWL)
- Market Cap
- CHF 37.43M
- Dividend Yield
- ―
- Average Volume (3M)
- 36.22K
- Price to Earnings (P/E)
- -2.2
- Beta (1Y)
- 0.73
- Revenue Growth
- -0.04%
- EPS Growth
- 46.39%
- Country
- Switzerland
- Employees
- 526
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Healthcare Information Services
Shl Telemedicine Business Overview & Revenue Model
Company Description
Established in 1987 and headquartered in Tel Aviv, Israel, SHL Telemedicine Ltd. is a global provider specializing in the development and distribution of individual remote healthcare solutions across Israel, Europe, and other international markets. T...
How the Company Makes Money
null
Shl Telemedicine Financial Statement Overview
Summary
Financial performance is weak. Revenue grew 8.2% to $61.5M, but gross margin fell to 37% from 45%, and the company remains unprofitable with a $16.1M net loss. Critically, operating and free cash flows are negative for the fifth consecutive year, indicating unsustainable cash burn despite a manageable debt-to-equity ratio of 0.30.
Income Statement
30NegativeBalance Sheet
45NeutralCash Flow
25Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 61.81M | 61.49M | 56.78M | 57.08M | 59.00M | 49.58M |
| Gross Profit | 28.40M | 22.89M | 25.79M | 25.26M | 27.19M | 24.59M |
| EBITDA | 4.00M | 3.28M | -18.15M | 3.02M | 9.48M | 5.59M |
| Net Income | -15.00M | -16.11M | -28.09M | -7.06M | -76.00K | -14.11M |
Balance Sheet | ||||||
| Total Assets | 83.61M | 84.56M | 80.76M | 113.05M | 110.78M | 129.59M |
| Cash, Cash Equivalents and Short-Term Investments | 19.38M | 25.26M | 17.52M | 26.25M | 18.70M | 32.06M |
| Total Debt | 10.75M | 13.08M | 16.12M | 19.86M | 26.74M | 32.50M |
| Total Liabilities | 40.29M | 40.82M | 41.51M | 36.59M | 51.49M | 68.83M |
| Stockholders Equity | 43.32M | 43.74M | 39.25M | 73.53M | 55.69M | 56.85M |
Cash Flow | ||||||
| Free Cash Flow | -2.22M | -3.48M | -4.04M | -6.99M | -1.73M | -3.07M |
| Operating Cash Flow | -869.38K | -1.90M | -372.00K | -1.50M | -73.00K | 185.00K |
| Investing Cash Flow | -5.93M | 7.93M | 6.03M | -9.35M | -6.43M | -40.97M |
| Financing Cash Flow | 6.77M | 11.02M | -4.87M | 13.67M | -2.28M | 51.08M |
Shl Telemedicine Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:SHLTN, the sentiment is Negative. The current price of 1.01 is below the 20-day moving average (MA) of 1.05, below the 50-day MA of 1.05, and below the 200-day MA of 1.04, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 43.97 is Neutral, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CH:SHLTN.
Shl Telemedicine Peers Comparison
Overall Rating
- CH:SHLTN42Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| CH:SHLTN | 42Neutral | CHF 37.43M | -2.19 | ― | ― | -0.04% | 46.39% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| CH:SHLTN | Shl Telemedicine | 1.01 | 0.33 | 47.66% |
Shl Telemedicine Corporate Events
SHL Telemedicine Faces Class Action Motion Over Subscription Pricing
SHL Telemedicine has disclosed that it received a motion seeking certification of a class action lawsuit alleging that the company charged excessive monthly subscription fees and implemented price increases in violation of service agreements and cons...
SHL Telemedicine Shareholders Approve Opting-Out Provision on Takeover Offers
SHL Telemedicine Ltd. reported that shareholders at a Special General Meeting approved the inclusion of an opting-out clause in the company’s Articles of Association under Swiss financial market law. The new provision states that any party crossing t...
SHL Telemedicine Pays Additional NIS 2.6 Million in Mediton and Medishur Deal Dispute
SHL Telemedicine Ltd. has confirmed the payment of an additional NIS 2.6 million, about USD 0.8 million, in indexation differentials and interest related to its purchase of stakes in Mediton Medical Centers Chain Ltd. and Medishur Ltd. The payment fo...
SHL Telemedicine Tightens Grip on Israeli Medical Centers With Mediton and Medishur Buyout
SHL Telemedicine has expanded its footprint in Israeli healthcare services by completing the purchase of an additional 27.5% stake in Mediton Medical Centers Chain and the remaining 30% of Medishur, for a total consideration of about NIS 28.9 million...
SHL Telemedicine Narrows Loss as Efficiency Gains Lift First-Half 2026 Results
SHL Telemedicine reported improved first-half 2026 results, with revenue rising 12% year-on-year to USD 31.3 million and adjusted EBITDA more than doubling to USD 1.8 million. Net loss narrowed to USD 3.9 million as cost-reduction measures and operat...
SHL Telemedicine Seeks Opt-Out From Swiss Mandatory Tender Offer Rules
SHL Telemedicine has called a Special General Meeting for September 17, 2026, where shareholders will vote on adding an opting-out clause to its articles of association under Swiss takeover law. The change would exempt investors surpassing 33â…“% of vo...
SHL Telemedicine to Fully Acquire Remaining Stakes in Israeli Subsidiaries After Court Ruling
SHL Telemedicine has received a judgment from the District Court in Israel requiring it to pay the full consideration for the remaining 30% stake in its subsidiaries Mediton Medical Centers Chain and Medishur. The court confirmed that SHL’s set-off c...
SHL Telemedicine Shareholders Approve Governance and Executive Option Changes at 2026 AGM
SHL Telemedicine has reported the results of its 2026 Annual General Meeting held in Tel Aviv, where shareholders approved several key governance and compensation measures. The company confirmed the reappointment of Kost Forer Gabbay & Kasierer, a me...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 30, 2026